Molecularly Targeted Therapies in Locally Advanced Non-Small-Cell Lung Cancer

被引：6

作者：

Devarakonda, Siddhartha ^{[1
]}

Morgensztern, Daniel ^{[2
]}

Govindan, Ramaswamy ^{[3
]}

机构：

[1] St Lukes Hosp, Dept Internal Med, Chesterfield, MO USA

[2] Yale Univ, Dept Med, New Haven, CT 06520 USA

[3] Washington Univ, Sch Med, Dept Med, St Louis, MO 63110 USA

来源：

CLINICAL LUNG CANCER | 2013年 / 14卷 / 05期

关键词：

Concurrent chemoradiation; Locally advanced NSCLC; NSCLC; Targeted therapy; GROWTH-FACTOR-RECEPTOR; RANDOMIZED PHASE-III; INDUCTION CHEMOTHERAPY; THORACIC RADIOTHERAPY; MAINTENANCE GEFITINIB; MONOCLONAL-ANTIBODY; IONIZING-RADIATION; CETUXIMAB; TRIAL; CHEMORADIOTHERAPY;

D O I：

10.1016/j.cllc.2013.03.005

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 [肿瘤学];

摘要：

Approximately a third of the patients with non-small cell lung cancer (NSCLC) present with locally advanced disease not amenable to curative resection. Concurrent chemoradiation is currently the treatment of choice for these patients. Outcomes in patients with locally advanced NSCLC treated with concurrent chemoradiation are modest at best. No significant progress has been made over the past decade in this subset of patients with NSCLC. Several trials have examined the role of molecular targeted therapies in this setting. We review the results of these trials and present the outline of a proposed prospective clinical trial to evaluate targeted drugs in molecularly selected group of patients with locally advanced NSCLC.

引用

页码：467 / 472

页数：6

共 45 条

[1]

Enhancement of the antitumor activity of ionising radiation by nimotuzumab, a humanised monoclonal antibody to the epidermal growth factor receptor, in non-small cell lung cancer cell lines of differing epidermal growth factor receptor status [J].

Akashi, Y. ;

Okamoto, I. ;

Iwasa, T. ;

Yoshida, T. ;

Suzuki, M. ;

Hatashita, E. ;

Yamada, Y. ;

Satoh, T. ;

Fukuoka, M. ;

Ono, K. ;

Nakagawa, K. .

BRITISH JOURNAL OF CANCER, 2008, 98 (04) :749-755

[2]

Molecular targeting in radiotherapy of lung cancer [J].

Baumann, M ;

Krause, M ;

Zips, D ;

Petersen, C ;

Dittmann, K ;

Dörr, W ;

Rodemann, HP .

LUNG CANCER, 2004, 45 :S187-S197

[3]

Phase I clinical trial of the anti-EGFR monoclonal antibody nimotuzumab with concurrent external thoracic radiotherapy in Canadian patients diagnosed with stage IIb, III or IV non-small cell lung cancer unsuitable for radical therapy [J].

Bebb, Gwyn ;

Smith, Colum ;

Rorke, Stewart ;

Boland, William ;

Nicacio, Leonardo ;

Sukhoo, Ryan ;

Brade, Anthony .

CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2011, 67 (04) :837-845

[4]

Exploitable mechanisms for combining drugs with radiation: concepts, achievements and future directions [J].

Bentzen, Soren M. ;

Harari, Paul M. ;

Bernier, Jacques .

NATURE CLINICAL PRACTICE ONCOLOGY, 2007, 4 (03) :172-180

[5]

Definitive chemoradiation for the treatment of locally advanced non-small-cell lung cancer [J].

Blackstock, A. William ;

Govindan, Ramaswamy .

JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (26) :4146-4152

[6]

Phase II Study of Cetuximab in Combination With Chemoradiation in Patients With Stage IIIA/B Non-Small-Cell Lung Cancer: RTOG 0324 [J].

Blumenschein, George R., Jr. ;

Paulus, Rebecca ;

Curran, Walter J. ;

Robert, Francisco ;

Fossella, Frank ;

Werner-Wasik, Maria ;

Herbst, Roy S. ;

Doescher, Philip O. ;

Choy, Hak ;

Komaki, Ritsuko .

JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (17) :2312-2318

[7]

The emerging role of nimotuzumab in the treatment of non-small cell lung cancer [J].

Boland, William ;

Bebb, Gwyn .

BIOLOGICS-TARGETS & THERAPY, 2010, 4 :289-298

[8]

A Phase I Study of Gefitinib with Concurrent Dose-Escalated Weekly Docetaxel and Conformal Three-Dimensional Thoracic Radiation Followed by Consolidative Docetaxel and Maintenance Gefitinib for Patients with Stage III Non-small Cell Lung Cancer [J].

Center, Brian ;

Petty, William Jeffrey ;

Ayala, Diandra ;

Hinson, William H. ;

Lovato, James ;

Capellari, James ;

Oaks, Timothy ;

Miller, Antonius A. ;

Blackstock, Arthur William .

JOURNAL OF THORACIC ONCOLOGY, 2010, 5 (01) :69-74

[9]

A phase I study of nimotuzumab in combination with radiotherapy in stages IIB-IV non-small cell lung cancer unsuitable for radical therapy: Korean results [J].

Choi, Hye Jin ;

Sohn, Joo Hyuk ;

Lee, Chang Geol ;

Shim, Hyo Sub ;

Lee, Ik-Jae ;

Yang, Woo Ick ;

Kwon, Ji Eun ;

Kim, Se Kyu ;

Park, Moo-Suk ;

Lee, Ju Hee ;

Kim, Joo Hang .

LUNG CANCER, 2011, 71 (01) :55-59

[10]

Phase I trial of erlotinib-based multimodality therapy for inoperable stage III non-small cell lung cancer [J].

Choong, Nicholas W. ;

Mauer, Ann M. ;

Haraf, Daniel J. ;

Lester, Eric ;

Hoffman, Philip C. ;

Kozloff, Mark ;

Lin, Shang ;

Dancey, Janet E. ;

Szeto, Livia ;

Grushko, Tatyana ;

Olopade, Olufunmilayo I. ;

Salgia, Ravi ;

Vokes, Everett E. .

JOURNAL OF THORACIC ONCOLOGY, 2008, 3 (09) :1003-1011

← 1 2 3 4 5 →